Abstract
Poor outcomes and high budget pressure are challenges in renal replacement therapy. Therefore, personalized treatment approaches such as intensive home haemodialysis (iHHD; > 3x4 hours a week) are evaluated for suitable patients on their cost reduction potential and outcome improvement. A large body of international evidence has been published on the benefits of iHHD. However, questions remain how these positive effects translate into benefits for specific health systems. This analysis aims to estimate the financial impact of iHHD on medication use and hospitalization for Italy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
